YOLFTbeta
30

ChemPartner PharmaTech Co Ltd

300149 · SHE · Healthcare / Biotechnology

8.43CNY-0.38 (-4.31%)

Price History

Full chart

Market Stats

Previous Close8.81
Open8.71
Day Range8.39 – 8.81
52-Week Range7.22 – 14.23
Volume20.63M
Market Cap5.00B
P/E (TTM)0.00
Forward P/E10.93
EPS-0.08
Dividend Yield0.00%
Beta0.69
50-Day Avg9.69
200-Day Avg9.96

About

ChemPartner PharmaTech Co.,Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services. The company provides comprehensive chemical drug research and development and biological drug services for pharmaceutical companies, biotechnology companies, and scientific research institutions. The company was formerly known as Quantum Hi-Tech (China) Biological Co., Ltd. and changed its name to ChemPartner PharmaTech Co.,Ltd. in September 2020. ChemPartner PharmaTech Co.,Ltd. was founded in 2000 and is headquartered in Guangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Swee Lian Woo
  • Employees1.77K
  • HeadquartersExchange Square, Guangzhou, China, 510031, China
  • Websitehttps://www.cppt.com.cn

Leadership

  • Mr. Swee Lian WooGM, Board Secretary & Chairman · b. 1961
  • Mr. Yunqun ZhaCFO & Accounting Supervisor · b. 1979
  • Mr. Wang Long ChenVP & Director · b. 1972

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue65.07M97.08M100.25M123.81M166.06M238.70M256.72M278.32M315.81M258.64M275.35M996.92M1.33B1.48B1.69B1.33B1.14B970.20M1.13B
Growth (%)-+49.20%+3.26%+23.51%+34.12%+43.74%+7.55%+8.41%+13.47%-18.10%+6.46%+262.05%+33.19%+11.58%+14.11%-21.54%-14.19%-14.77%+16.96%
Cost of Revenue35.47M50.81M45.84M61.93M103.36M135.44M132.83M126.50M141.79M128.00M149.74M569.91M820.82M913.92M1.15B989.33M843.13M758.70M810.03M
Gross Profit---------130.64M125.61M427.00M507.01M567.67M535.77M337.26M295.24M211.51M324.69M
Gross Margin---------50.51%45.62%42.83%38.18%38.32%31.69%25.42%25.94%21.80%28.61%
Operating Expense---------61.73M71.94M231.92M298.70M352.34M446.13M398.73M332.71M254.25M285.60M
Operating Income14.15M28.07M34.60M35.48M23.37M35.39M29.63M41.45M62.18M68.91M53.67M195.08M208.31M215.33M89.64M-61.48M-37.47M-42.74M39.10M
Operating Margin21.75%28.91%34.51%28.66%14.08%14.83%11.54%14.89%19.69%26.64%19.49%19.57%15.69%14.53%5.30%-4.63%-3.29%-4.41%3.45%
EBITDA----------86.74M277.05M296.71M349.79M-91.37M1.00B-768.84M-73.75M149.15M
EBITDA Margin----------31.50%27.79%22.35%23.61%-5.40%75.68%-67.54%-7.60%13.14%
Net Income11.98M23.18M29.39M33.75M27.50M35.28M39.73M40.70M59.47M64.98M57.81M161.08M138.92M154.55M-402.25M378.59M-916.75M-226.47M13.41M
Net Income Margin18.41%23.88%29.32%27.26%16.56%14.78%15.48%14.62%18.83%25.12%20.99%16.16%10.46%10.43%-23.79%28.54%-80.53%-23.34%1.18%
R&D-------16.04M21.06M13.15M14.60M55.28M62.89M71.68M124.65M92.28M77.47M59.55M59.84M
R&D as % of Total Revenue-------5.76%6.67%5.08%5.30%5.55%4.74%4.84%7.37%6.96%6.81%6.14%5.27%
Interest Expense0000000000033.25M51.80M51.06M78.73M66.48M31.30M26.10M15.86M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.34%3.90%3.45%4.66%5.01%2.75%2.69%1.40%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets67.79M86.93M136.30M587.42M633.82M667.61M703.99M741.13M756.00M793.16M1.04B3.35B3.77B4.12B4.22B3.82B2.43B2.00B2.03B
Total Liabilities43.53M28.57M35.04M16.12M22.37M26.72M33.70M44.60M32.19M23.23M207.73M1.14B1.46B1.67B2.23B1.44B973.44M757.75M732.59M
Total Equity24.05M58.15M101.26M571.30M589.76M617.00M646.59M675.23M723.74M769.86M811.58M2.19B2.29B2.43B1.96B2.36B1.44B1.21B1.28B
Cash22.62M18.71M28.72M454.74M434.39M358.16M292.51M271.74M50.07M112.05M291.50M190.80M201.05M259.12M160.46M761.66M347.26M368.33M411.83M
Net Debt-----------439.07M504.05M645.51M613.02M----

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow22.19M21.70M13.28M20.81M11.66M55.09M46.32M59.63M100.69M71.26M63.43M243.19M215.07M343.16M378.22M262.46M150.99M168.21M190.50M
Investing Cash Flow---------10.80M-68.67M-940.44M-255.13M-407.01M-210.89M1.01B---
Financing Cash Flow2.36M-14.20M422.01M------20.63M185.33M594.27M48.03M114.16M-259.36M-860.11M---
Capital Expenditure6.45M24.33M18.83M16.89M21.06M124.91M63.17M76.93M25.33M10.45M4.21M109.88M254.23M394.03M286.00M336.20M201.29M69.25M62.47M
Free Cash Flow----------59.22M133.30M-39.16M-50.87M92.22M-73.74M-50.30M98.96M128.03M
Dividends Paid338.00K980.00K4.76M6.07M9.06M8.04M10.44M12.06M12.06M21.11M21.11M45.79M79.75M57.10M81.14M37.40M6.24M2.88M2.90M
FCF to OCF----------93.36%54.81%-18.21%-14.82%24.38%-28.10%-33.31%58.83%67.21%
Dividend Paid to FCF----------35.64%34.35%-203.66%-112.23%87.99%-50.72%-12.41%2.91%2.27%

Earnings

Report DateMar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 25, 2016Sep 30, 2016Feb 24, 2017Apr 26, 2017Aug 14, 2017Oct 30, 2017Dec 31, 2017Apr 27, 2018Aug 29, 2018Oct 26, 2018Dec 31, 2018Apr 11, 2019Aug 26, 2019Oct 27, 2019Dec 31, 2019Apr 27, 2020Aug 27, 2020Oct 29, 2020Dec 31, 2020Apr 28, 2021Aug 29, 2021Oct 28, 2021Dec 31, 2021Apr 29, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Apr 26, 2023Aug 28, 2023Oct 24, 2023Jan 10, 2024Apr 25, 2024Jun 30, 2024Oct 29, 2024Dec 31, 2024Apr 28, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------------------------
EPS Actual0.010.010.020.020.020.030.020.020.020.030.030.020.020.030.040.020.030.030.070.010.040.040.050.030.030.050.040.020.030.090.120.100.050.050.060.120.120.110.090.140.000.010.02-0.84-0.861.900.13-1.29-0.060.01-0.04-1.74-0.05-0.080.00-0.330.010.04-0.040.01-0.04-0.03
Surprise--------------------------------------------------------------
Timing---------------------Pre-market-Pre-marketPre-marketPre-market--Pre-marketAfter-hoursPre-market-Pre-marketPre-marketAfter-hours-Pre-marketPre-marketAfter-hours-Pre-marketAfter-hoursPre-market-Pre-market---After-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-Pre-market-After-hours-----

Key Statistics & Ratios

Market Cap5.00B
Enterprise Value5.07B
Trailing P/E0.00
Forward P/E10.93
PEG Ratio0.00
Price / Sales4.24
Price / Book3.96
EPS-0.08
Book Value2.56
Revenue (TTM)1.16B
Gross Profit (TTM)311.27M
EBITDA30.17M
Profit Margin-3.69%
Operating Margin0.42%
Return on Equity-3.29%
Return on Assets-0.60%
Shares Outstanding504.99M
Shares Float294.75M
Beta0.69
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20211×
0.07Jun 1, 2021
20191×
0.07Jun 12, 2019
20181×
0.04May 30, 2018
20171×
0.05May 22, 2017
20161×
0.05Jun 8, 2016
20151×
0.03May 21, 2015
20141×
0.03May 21, 2014
20131×
0.02Apr 22, 2013
20121×
0.03May 18, 2012
20111×
0.02May 9, 2011

Stock Splits

  • May 21, 201514:10
  • May 21, 201415:10
  • May 18, 201215:10
  • May 9, 201120:10